JS

Jaskaran Sandhu

Active Director Director DIN 10275323
DIN 10275323 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Jaskaran Sandhu

Data last updated:

Jaskaran Sandhu is a Director at Ameidic Biiotech Private Limited (since 2023). The company operates in Paper. Ameidic Biiotech Private Limited reported revenue of ₹22,500 (FY 2025).

DIN 10275323
Primary Designation Director
Industry Paper
First Appointment 10 Aug 2023
Oldest Company Age 3 yrs
Largest company Ameidic Biiotech Private Limited · ₹22,500 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ameidic Biiotech Private Limited U21001HR2023PTC114067
Director10 Aug 20232023₹22,500 (FY 2025)Active

Board colleagues of Jaskaran Sandhu

Directorship timeline

Open interactive timeline →
Ameidic Biiotech Private Limited
Premium access

Shareholding and investment profile for Jaskaran Sandhu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaskaran Sandhu

Jaskaran Sandhu currently holds 1 directorship: Ameidic Biiotech Private Limited (Director, since 10 Aug 2023, revenue ₹22,500 (FY 2025)).

Jaskaran Sandhu was first appointed on 10 Aug 2023 as Director at Ameidic Biiotech Private Limited.

The current boards of Jaskaran Sandhu's companies include Dilbagh Manmohan Singh (Ameidic Biiotech Private Limited), Sonia Sandhu (Ameidic Biiotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available